10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 322 filers reported holding 10X GENOMICS INC in Q1 2021. The put-call ratio across all filers is 1.39 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $373,106 | -26.1% | 9,045 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $505,073 | -14.8% | 9,045 | -14.9% | 0.00% | 0.0% |
| Q1 2023 | $593,103 | -36.9% | 10,631 | -58.8% | 0.00% | -66.7% |
| Q4 2022 | $939,350 | -86.7% | 25,778 | -89.6% | 0.00% | -85.7% |
| Q3 2022 | $7,050,000 | +40.0% | 247,528 | +122.5% | 0.02% | +50.0% |
| Q2 2022 | $5,034,000 | +251600.0% | 111,233 | +347503.1% | 0.01% | – |
| Q1 2022 | $2,000 | -100.0% | 32 | -99.9% | 0.00% | -100.0% |
| Q4 2020 | $7,174,000 | +473.0% | 50,662 | +404.4% | 0.02% | +400.0% |
| Q3 2020 | $1,252,000 | – | 10,044 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |